The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targeting smaller patient populations, are reshaping how drugs are produced and sold.
To keep up with this change, you can download an e-book full of insights on current biomanufacturing trends. In the e-book, six industry experts share their bioprocess visions and advise on digital automation, innovative process approaches, and more.
Trends in the biopharmaceutical market: Are you ready for the future of manufacturing?
With a rise in biosimilars, niche drugs, and therapeutic and molecular innovation, the biopharma market is seeing dramatic changes. As it continues to evolve, there are significant challenges we must overcome in order to deliver these therapies to patients.
By Dr. Nigel Darby, Advisor, GE Healthcare Life Sciences
Modular approaches for diverse molecules: Reinventing smart bioprocessing
To meet the pressure to find more efficient and effective production processes, Rentschler Biopharma is using an approach it calls “smart bioprocessing”. The approach uses bioinformatics, lab-scale processing, and analytics to rapidly create scalable manufacturing processes that can be verified at lab-scale before scale-up.
By Dr. Stefan R. Schmidt, MBA, Chief Scientific Officer, Rentschler Biopharma
Industry 4.0: Embracing digital transformation in bioprocessing
There have been several different industrial revolutions over time, all enabled by a significant leap in productivity. Now, another transformation is taking place that will pave the way for even more changes to how the industry approaches drug manufacturing. Its benefits for bioprocessing are too substantial to ignore.
By Per Lidén, Product Strategy Manager, GE Healthcare Life Sciences
Are today’s processes efficient enough for the future of vaccine and viral vector production?
The vaccine market is changing. Viral vector-based vaccines and other therapies are becoming essential to the treatment of many diseases, sparking new interest across the industry. To be successful in this diverse and growing market, it is essential to recognize the limitations of today’s production processes.
By Dr. Mats Lundgren, Customer Applications Director, GE Healthcare Life Sciences
Striving for bioprocessing excellence: Balancing modern approaches to manufacturing
Biomanufacturers might have to embrace change to remain competitive in this growing market. Several modern downstream technologies available today can improve efficiency and even quality. It is important to understand the benefits of each these options and how they can be used to forge a path toward bioprocessing excellence.
By Madhu Raghunathan, Product Strategy Leader, GE Healthcare Life Sciences
Optimizing process efficiency in upstream manufacturing
Process efficiency is a key goal for biopharmaceutical production. Here you get details on several different approaches and technologies that can significantly improve the efficiency of upstream processing. These include cell line development, process development and process intensification, real-time analytics, and process integration.
By Dr. Andreas Castan, Staff Scientist, GE Healthcare Life Sciences